TR201010860A2 - Sefdinir formulasyonları için üretim yöntemi. - Google Patents

Sefdinir formulasyonları için üretim yöntemi.

Info

Publication number
TR201010860A2
TR201010860A2 TR2010/10860A TR201010860A TR201010860A2 TR 201010860 A2 TR201010860 A2 TR 201010860A2 TR 2010/10860 A TR2010/10860 A TR 2010/10860A TR 201010860 A TR201010860 A TR 201010860A TR 201010860 A2 TR201010860 A2 TR 201010860A2
Authority
TR
Turkey
Prior art keywords
production method
cefdinir
formulations
cefdinir formulations
processes
Prior art date
Application number
TR2010/10860A
Other languages
English (en)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from TR2010/09167A external-priority patent/TR201009167A2/tr
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2010/10860A priority Critical patent/TR201010860A2/tr
Priority to PCT/TR2011/000254 priority patent/WO2012060789A2/en
Priority to PCT/TR2011/000258 priority patent/WO2012060793A2/en
Publication of TR201010860A2 publication Critical patent/TR201010860A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Mevcut buluş, aktif ajan olarak sefdinir içeren formülasyonların hazırlanmasında kullanılacak proseslere ve bu prosesle elde edilecek farmasötik bileşimlere ilişkindir.
TR2010/10860A 2010-11-05 2010-12-24 Sefdinir formulasyonları için üretim yöntemi. TR201010860A2 (tr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2010/10860A TR201010860A2 (tr) 2010-11-05 2010-12-24 Sefdinir formulasyonları için üretim yöntemi.
PCT/TR2011/000254 WO2012060789A2 (en) 2010-11-05 2011-11-03 Production method for cefdinir formulations
PCT/TR2011/000258 WO2012060793A2 (en) 2010-11-05 2011-11-03 Process for the preparation of cefdinir formulations

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2010/09167A TR201009167A2 (tr) 2010-11-05 2010-11-05 Sefalosporin içeren farmasötik granüller.
TR2010/10860A TR201010860A2 (tr) 2010-11-05 2010-12-24 Sefdinir formulasyonları için üretim yöntemi.

Publications (1)

Publication Number Publication Date
TR201010860A2 true TR201010860A2 (tr) 2012-05-21

Family

ID=45607339

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2010/10860A TR201010860A2 (tr) 2010-11-05 2010-12-24 Sefdinir formulasyonları için üretim yöntemi.

Country Status (2)

Country Link
TR (1) TR201010860A2 (tr)
WO (2) WO2012060793A2 (tr)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA836918B (en) 1982-09-30 1984-05-30 Fujisawa Pharmaceutical Co 7-substituted-3-vinyl-3-cephem compounds and processes for the production of the same
DE3887179T2 (de) * 1987-03-02 1994-06-16 Brocades Pharma Bv Pharmazeutische Zusammensetzung, pharmazeutisches Granulat und Verfahren zu ihrer Herstellung.
KR20050062514A (ko) * 2002-07-16 2005-06-23 랜박시 래보러터리스 리미티드 경구 투여용 분산성 정제
CA2433962C (en) * 2002-07-19 2012-10-30 Abbott Laboratories Antibacterial clarithromycin compositions and processes for making the same
JP2006527064A (ja) * 2004-05-31 2006-11-30 サンア ファーマシューティカルス カンパニー リミテッド β−ラクタム系抗生物質を含む懸濁錠剤及びその製造方法
WO2007058397A1 (en) * 2005-11-17 2007-05-24 Gl Pharmtech Corp. A dispersible tablet comprising the mixture of amoxicillin and clavulanic acid or its salts and processes for preparing the same

Also Published As

Publication number Publication date
WO2012060789A3 (en) 2012-06-28
WO2012060793A3 (en) 2012-06-28
WO2012060793A2 (en) 2012-05-10
WO2012060789A2 (en) 2012-05-10

Similar Documents

Publication Publication Date Title
NZ704662A (en) Crystalline forms of the prolyl hydroxylase inhibitor [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid
PH12013502284A1 (en) Protein-active agent conjugates and method for preparing the same
EA201290980A1 (ru) Производные 1-амино-2-циклопропилэтилбороновой кислоты
UA113651C2 (xx) Макроциклічні пурини для лікування вірусних інфекцій
SG195086A1 (en) Compounds containing hydrido-tricyano-borate anions
EA201400833A1 (ru) Новые индолизиновые соединения, способ их получения и фармацевтические композиции, содержащие их
UA111198C2 (uk) Похідні 1-феніл-2-піридинілалкільних спиртів як інгібітори фосфодіестерази
PH12014501967B1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
GB201205769D0 (en) Methods for preparing samples for nucleic acid amplification
BR112012032248A2 (pt) composições de 5-etil-2-{4-[-4(-4-tetrazol-1-il-fenoximetil)-tiazol-2-il]-piperidin-1-il}-pirimidina
PH12015501175A1 (en) Substituted pyridopyrazines as syk inhibitors
TR201009167A2 (tr) Sefalosporin içeren farmasötik granüller.
MX2015006986A (es) Solucion de trombina y metodos de uso de esta.
BR112015031820A2 (pt) composto, composição farmacêutica, intermediário, processo para a preparação de um composto e métodos
PH12015500061A1 (en) Method for preparing substituted triazolopyridines
EA201492280A1 (ru) Стабильный состав пексиганана
MX2015005510A (es) Forma salina solida de la alfa-6-mpeg6-o-hidroxicodona como agonistas opioides y sus usos.
WO2011093831A3 (en) Effervescent formulations comprising cefprozil as active agent
TR200909785A1 (tr) Aktif ajan olarak sefdinir içeren farmasötik kompozisyonlar.
IN2014DN10135A (tr)
TR201010859A2 (tr) Sefdinir içeren tablet formları.
TR201009166A2 (tr) Sefdinir içeren farmasötik bileşim için üretim yöntemi
MX352620B (es) Polimeros de condensacion de acido mandelico.
TR201104864A2 (tr) Deksketoprofen içeren suda çözünebilir formülasyonlar.
TR201009165A2 (tr) Sefdinir içeren tabletler